NCT05313386View on ClinicalTrials.gov

Study of BXCL501 In Agitation Associated With Delirium in ICU Patients

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 23, 2021

Primary Completion Date

February 21, 2022

Study Completion Date

February 21, 2022

Conditions
AgitationDelirium
Interventions
DRUG

BXCL501

BXCL501 is given in a film form

DRUG

Placebo film

Placebo is given in a film form

Trial Locations (1)

37203

BioXcel Clinical Research Site, Nashville

Sponsors
All Listed Sponsors
collaborator

Cognitive Research Corporation

INDUSTRY

lead

BioXcel Therapeutics Inc

INDUSTRY